Daratumumab Is Safe and Effective for the Treatment of Refractory Autoimmunity in Children

Authors :: Ashok Kumar
Pooja Khandelwal
Michael B. Jordan
Ashley Teusink-Cross
Adam S. Nelson
Rebecca A. Marsh
Jack J. Bleesing
Stella M. Davies
Parinda A. Mehta
Sharat Chandra
Source :: Transplantation and Cellular Therapy. 27:S459-S460
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Transplantation
Refractory
business.industry
Immunology
Molecular Medicine
Immunology and Allergy
Medicine
Daratumumab
Cell Biology
Hematology
business
medicine.disease_cause
Autoimmunity

Full Text Access

Tools